InViragen to Participate in Biotechnology Industry Organization (BIO) Ventures for Global Health Press Briefing June 18

Published: Jun 14, 2012

FORT COLLINS, Colo.--(BUSINESS WIRE)--Inviragen has been invited to participate in a press conference hosted by BIO Ventures for Global Health (BVGH) during the annual Biotechnology Industry Organization international convention taking place June 18-21, 2012 at the Boston Convention & Exhibition Center, MA. During the press briefing, which is being held at 9:00am ET on June 18, a report developed by BVGH and BIO titled Biotechnology: Bringing Innovation to Neglected Disease Research and Development will be publicly released. The report discusses the role of biotechnology companies in developing innovative new health care products for neglected diseases in the developing world. Inviragen’s efforts to develop vaccines for unmet needs in Asia and the Americas are highlighted in the report. Dr. Dan Stinchcomb, chief executive officer of Inviragen will join a triad of industry executives who will provide insight on their research and development of diagnostics, drugs and vaccines to address neglected diseases worldwide.

Back to news